US › Healthcare

CryoCell International Inc (CCEL)

US · Healthcare · Medical Care Facilities

$4.42+21.10%

Last close · 2026-10-16

Latest quarter · ended 2026-05-31

Revenue

$7.8M

Revenue YoY

-1.9%

Net profit

$554,586

Profit YoY

+55.9%

EPS

$0.07

Net margin

7.1%

Key statistics

Market cap

$35.2M

Forward P/E

2,000.0

P/B

9.72

Book value

$-2.03

EPS (TTM)

$-0.24

52-week high

$4.90

52-week low

$2.72

50-day MA

$4.03

200-day MA

$3.59

Beta

0.59

Analyst view

Analysts rate CryoCell International Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $8.50.

Shareholding

Insiders

34.59%

Institutions

13.72%

Largest institutional holders

Fund	Stake
SFI Advisors, LLC	2.05%
Vanguard Capital Management, LLC	2.05%
MASSMUTUAL TRUST CO FSB/ADV	1.38%
Geode Capital Management, LLC	0.57%
Vanguard Fiduciary Trust Co	0.29%
FMR Inc	0.25%
Susquehanna International Group, LLP	0.17%
BlackRock Inc	0.08%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for CryoCell International Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.